血常规衍生炎症标志物在心血管疾病中的研究进展
Research Progress of Blood Routine Derived Inflammatory Markers in Cardiovascular Diseases
DOI: 10.12677/acm.2025.1541083, PDF,   
作者: 祝逸群, 王 曦*：重庆医科大学附属第一医院心血管内科心血管研究中心，重庆
关键词: 血常规；炎症；心血管疾病；Blood Routine； Inflammation； Cardiovascular Disease
摘要: 血常规是临床常用的检查，通过复合其中的中性粒细胞、淋巴细胞、单核细胞等衍生的相关炎症标志物被认为可以更好地反映机体免疫炎症状态，并已在临床及科研中被证实对许多疾病有一定预测价值。本文就目前对相关炎症标志物与心血管疾病的关联性进行的相关研究结果进行综述。
Abstract: Blood routine is a commonly used clinical examination. It is considered that the combination of neutrophils, lymphocytes, monocytes and other related inflammatory markers can better reflect the immune inflammatory state of the body, and has been proved to have certain predictive value for many diseases in clinical and scientific research. In this paper, we review the results of current studies on the correlation between inflammatory markers and cardiovascular diseases.
文章引用：祝逸群, 王曦. 血常规衍生炎症标志物在心血管疾病中的研究进展[J]. 临床医学进展, 2025, 15(4): 1487-1493. https://doi.org/10.12677/acm.2025.1541083

参考文献

[1] 刘明波, 何新叶, 杨晓红, 等. 《中国心血管健康与疾病报告2023》概要(心血管疾病流行及介入诊疗状况) [J]. 中国介入心脏病学杂志, 2024, 32(10): 541-550.
[2] 黄凯, 王美堂. 血常规衍生免疫炎症标志物与急性缺血性脑卒中相关性的研究进展[J]. 临床急诊杂志, 2023, 24(11): 604-608.
[3] 罗明波, 周晖, 罗卓迪, 等. 血常规衍生炎症指标在寻常型银屑病中的表达及意义[J]. 热带医学杂志, 2019, 19(6): 683-686, 718.
[4] 王婷婷, 马慧珍, 邓小岚, 等. 血常规中炎症指标与衰弱及衰弱前期的关系[J]. 实用临床医药杂志, 2022, 26(19): 87-91.
[5] Ross, R. (1993) The Pathogenesis of Atherosclerosis: A Perspective for the 1990s. Nature, 362, 801-809. [Google Scholar] [CrossRef] [PubMed]
[6] Todosenko, N., Khaziakhmatova, O., Malashchenko, V., Yurova, K., Bograya, M., Beletskaya, M., et al. (2023) Adipocyte-and Monocyte-Mediated Vicious Circle of Inflammation and Obesity (Review of Cellular and Molecular Mechanisms). International Journal of Molecular Sciences, 24, Article 12259. [Google Scholar] [CrossRef] [PubMed]
[7] Song, J., Farris, D., Ariza, P., Moorjani, S., Varghese, M., Blin, M., et al. (2023) Age‐Associated Adipose Tissue Inflammation Promotes Monocyte Chemotaxis and Enhances Atherosclerosis. Aging Cell, 22, e13783. [Google Scholar] [CrossRef] [PubMed]
[8] Ley, K., Miller, Y.I. and Hedrick, C.C. (2011) Monocyte and Macrophage Dynamics during Atherogenesis. Arterio-sclerosis, Thrombosis, and Vascular Biology, 31, 1506-1516. [Google Scholar] [CrossRef] [PubMed]
[9] Xi, J., Men, S., Nan, J., Yang, Q. and Dong, J. (2022) The Blood Monocyte to High Density Lipoprotein Cholesterol Ratio (MHR) Is a Possible Marker of Carotid Artery Plaque. Lipids in Health and Disease, 21, Article No. 144.
[10] Wang, H., Shi, W., Yi, X., Zhou, Y., Wang, Z. and Sun, Y. (2019) Assessing the Performance of Monocyte to High-Density Lipoprotein Ratio for Predicting Ischemic Stroke: Insights from a Population-Based Chinese Cohort. Lipids in Health and Disease, 18, Article No. 127. [Google Scholar] [CrossRef] [PubMed]
[11] Jiang, M., Yang, J., Zou, H., Li, M., Sun, W. and Kong, X. (2022) Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio (MHR) and the Risk of All-Cause and Cardiovascular Mortality: A Nationwide Cohort Study in the United States. Lipids in Health and Disease, 21, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[12] Kanbay, M., Solak, Y., Unal, H.U., Kurt, Y.G., Gok, M., Cetinkaya, H., et al. (2014) Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Events in Patients with Chronic Kidney Disease. International Urology and Nephrology, 46, 1619-1625. [Google Scholar] [CrossRef] [PubMed]
[13] Soehnlein, O. (2012) Multiple Roles for Neutrophils in Atherosclerosis. Circulation Research, 110, 875-888. [Google Scholar] [CrossRef] [PubMed]
[14] Luo, J., Thomassen, J.Q., Nordestgaard, B.G., Tybjærg-Hansen, A. and Frikke-Schmidt, R. (2023) Neutrophil Counts and Cardiovascular Disease. European Heart Journal, 44, 4953-4964. [Google Scholar] [CrossRef] [PubMed]
[15] Fernández-Ruiz, I. (2019) Neutrophil-Driven SMC Death Destabilizes Atherosclerotic Plaques. Nature Reviews Cardiology, 16, 455-455. [Google Scholar] [CrossRef] [PubMed]
[16] Chen, G., Yang, N., Ren, J., He, Y., Huang, H., Hu, X., et al. (2020) Neutrophil Counts to High-Density Lipoprotein Cholesterol Ratio: A Potential Predictor of Prognosis in Acute Ischemic Stroke Patients after Intravenous Thrombolysis. Neurotoxicity Research, 38, 1001-1009. [Google Scholar] [CrossRef] [PubMed]
[17] Zhou, Y., Dan, H., Bai, L., Jia, L., Lu, B. and Cui, W. (2022) Nonlinear Relationship with Saturation Effect Observed between Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Atherosclerosis in a Health Examination Population: A Cross‐Sectional Study. BMC Cardiovascular Disorders, 22, Article No. 424. [Google Scholar] [CrossRef] [PubMed]
[18] Nunez, J., Minana, G., Bodi, V., Nunez, E., Sanchis, J., Husser, O., et al. (2011) Low Lymphocyte Count and Cardiovascular Diseases. Current Medicinal Chemistry, 18, 3226-3233. [Google Scholar] [CrossRef] [PubMed]
[19] Blum, A. (1998) Role of Lymphocytes in Heart Disease. Circulation, 98, 1590. [Google Scholar] [CrossRef] 
[20] Charach, G., Grosskopf, I., Galin, L., Robinson, E., Hershenson, R. and Charach, L. (2021) Usefulness of Cardiac Biomarkers for Prognosis of Better Outcomes in Chronic Heart Failure: Retrospective 18-Year Follow-Up Study! Medicine, 100, e23464. [Google Scholar] [CrossRef] [PubMed]
[21] Papa, A., Emdin, M., Passino, C., Michelassi, C., Battaglia, D. and Cocci, F. (2008) Predictive Value of Elevated Neutrophil-Lymphocyte Ratio on Cardiac Mortality in Patients with Stable Coronary Artery Disease. Clinica Chimica Acta, 395, 27-31. [Google Scholar] [CrossRef] [PubMed]
[22] Balta, S., Celik, T., Mikhailidis, D.P., Ozturk, C., Demirkol, S., Aparci, M., et al. (2015) The Relation between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clinical and Applied Thrombosis/Hemostasis, 22, 405-411. [Google Scholar] [CrossRef] [PubMed]
[23] Agarwal, R., Aurora, R.G., Siswanto, B.B. and Muliawan, H.S. (2021) The Prognostic Value of Neutrophil-to-Lymphocyte Ratio across All Stages of Coronary Artery Disease. Coronary Artery Disease, 33, 137-143. [Google Scholar] [CrossRef] [PubMed]
[24] Maleki, M., Tajlil, A., Separham, A., Sohrabi, B., Pourafkari, L., Roshanravan, N., et al. (2021) Association of Neutrophil to Lymphocyte Ratio (NLR) with Angiographic SYNTAX Score in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS). Journal of Cardiovascular and Thoracic Research, 13, 216-221. [Google Scholar] [CrossRef] [PubMed]
[25] Kuckleburg, C.J., Yates, C.M., Kalia, N., Zhao, Y., Nash, G.B., Watson, S.P., et al. (2011) Endothelial Cell-Borne Platelet Bridges Selectively Recruit Monocytes in Human and Mouse Models of Vascular Inflammation. Cardiovascular Research, 91, 134-141. [Google Scholar] [CrossRef] [PubMed]
[26] Huo, Y., Schober, A., Forlow, S.B., Smith, D.F., Hyman, M.C., Jung, S., et al. (2002) Circulating Activated Platelets Exacerbate Atherosclerosis in Mice Deficient in Apolipoprotein E. Nature Medicine, 9, 61-67. [Google Scholar] [CrossRef] [PubMed]
[27] Dong, G., Huang, A. and Liu, L. (2020) Platelet‐to‐Lymphocyte Ratio and Prognosis in STEMI: A Meta‐Analysis. European Journal of Clinical Investigation, 51, e13386. [Google Scholar] [CrossRef] [PubMed]
[28] Zhu, X., Li, G., Li, S., Gong, Z., Liu, J. and Song, S. (2020) Neutrophil-to-Lymphocyte Ratio and Red Blood Cell Distribution Width-to-Platelet Ratio Predict Cardiovascular Events in Hemodialysis Patients. Experimental and Therapeutic Medicine, 20, 1105-1114. [Google Scholar] [CrossRef] [PubMed]
[29] Hu, B., Yang, X., Xu, Y., Sun, Y., Sun, C., Guo, W., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef] [PubMed]
[30] Ye, Z., Hu, T., Wang, J., Xiao, R., Liao, X., Liu, M., et al. (2022) Systemic Immune-Inflammation Index as a Potential Biomarker of Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine, 9, Article 933913. [Google Scholar] [CrossRef] [PubMed]
[31] Gao, C., Gao, S., Zhao, R., et al. (2024) Association between Systemic Immune-Inflammation Index and Cardiovascular-Kidney-Metabolic Syndrome. Scientific Reports, 14, Article No. 19151.
[32] Yang, Y., Wu, C., Hsu, P., Chen, S., Huang, S., Chan, W.L., et al. (2020) Systemic Immune‐Inflammation Index (SII) Predicted Clinical Outcome in Patients with Coronary Artery Disease. European Journal of Clinical Investigation, 50, e13230. [Google Scholar] [CrossRef] [PubMed]
[33] Chao, B., Ju, X., Zhang, L., Xu, X. and Zhao, Y. (2020) A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients. Frontiers in Oncology, 10, Article 766. [Google Scholar] [CrossRef] [PubMed]
[34] Dong, W., Gong, Y., Zhao, J., Wang, Y., Li, B. and Yang, Y. (2024) A Combined Analysis of Tyg Index, SII Index, and SIRI Index: Positive Association with CHD Risk and Coronary Atherosclerosis Severity in Patients with NAFLD. Frontiers in Endocrinology, 14, Article 1281839. [Google Scholar] [CrossRef] [PubMed]
[35] Xia, Y., Xia, C., Wu, L., Li, Z., Li, H. and Zhang, J. (2023) Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. Journal of Clinical Medicine, 12, Article 1128. [Google Scholar] [CrossRef] [PubMed]

为你推荐